Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
about
Identification of an Epstein-Barr virus-coded thymidine kinase.Progress and problems in understanding and managing primary Epstein-Barr virus infections6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virusInhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virusComparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replicationComparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virusActivity of penciclovir against Epstein-Barr virusA phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.Simultaneous determination of acyclovir, ganciclovir, and (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in human plasma using high-performance liquid chromatography.Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virusPopulation pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients.Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon.The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein-Barr virus diseasePotent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.Antiviral therapy: current concepts and practicesThe Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned geneInhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication.Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probesDifferential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line.Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase.In vitro and in vivo inhibition of murine gamma herpesvirus 68 replication by selected antiviral agents.Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.Identification of two T-cell epitopes on the candidate Epstein-Barr virus vaccine glycoprotein gp340 recognized by CD4+ T-cell clones.A rapid DNA hybridization assay for the evaluation of antiviral compounds against Epstein-Barr virus.Characterization of the Epstein-Barr virus-encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems.Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.Valacyclovir pharmacokinetics and exploratory pharmacodynamics in young adults with Epstein-Barr virus infectious mononucleosis.
P2860
Q24531739-02EF68C9-67D6-4F65-8D34-519F249158DEQ24597706-E8CE0C6C-35D9-4D06-9F61-66FBF4600038Q28321395-5D2CB30E-83EE-4065-842D-E7234E0688F4Q28343493-49817826-856B-43B1-B215-82D38DD9AB09Q28359820-4416D910-D588-410C-B0DF-16F16241306CQ28359881-7932AE9E-D7CD-42E9-B87B-1C5936BF79F5Q28360310-F06AE4A5-A348-4CF3-8790-9F2647F375CEQ28367461-9E95E47B-467D-46CE-8813-77743666DB8DQ30496656-73763B9A-0174-4406-86C9-ED6ABFB77996Q33428636-95F93C43-F367-4E5D-AE53-F3B46FBACEFBQ33928152-D4F54389-D067-4D52-BC37-4DFB1874E021Q34065300-35226EAD-7FB6-4A33-892E-C784E2F87C6DQ35541334-6D5DE622-546C-43ED-AFF7-594A5AB131A6Q35541809-6D68BD55-27F8-4163-AD64-7EF935E97A60Q35649603-BA4CE939-EC18-404C-B8D2-036B0948D590Q35683931-CC307BF7-0F70-4D5E-B7DA-B0C04DCF5229Q35816739-7029A329-7624-4BCE-895E-95E17F334307Q36070394-3C2B3215-6D2D-4C00-917E-B47E28BA7BAEQ36687455-2A52BDF6-FA34-4A12-8CBC-A2442A665DEDQ36689248-36C519BD-5918-437B-BF78-C8796F664FEEQ36757291-8E98704B-9432-475F-AC85-730A3DD10A55Q36865371-B2CB78F4-49EA-4452-8658-BCDC319F9835Q36884995-C9114CC0-7C64-4D2C-AAD3-12B395357508Q36889039-5749EA08-F265-4AAF-A178-987E4A076744Q36904495-3342158F-5515-4639-A8A8-2B02039843A9Q39557022-6CB137E8-42D7-4FD2-BCF4-6BF5779E5C5DQ39585366-A67F564D-C747-4032-8DA6-EBD0AC1ABFADQ39753081-5C061FC8-CA3A-422E-B401-DDB2794B21F8Q40067251-FFC512D5-55A0-4725-9716-4032F4259800Q40125731-5D3B60E2-0825-43A0-B061-5559CFE96595Q40129395-FCDB00D0-D21A-4283-94B5-CC450D33D097Q40594969-C5FA9E66-B173-4344-B67F-640025D1E7EEQ43246208-4367EBD2-FA73-48B5-85F0-209167E3EF4C
P2860
Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Prolonged inhibitory effect of ...... ication of Epstein-Barr virus.
@en
type
label
Prolonged inhibitory effect of ...... ication of Epstein-Barr virus.
@en
prefLabel
Prolonged inhibitory effect of ...... ication of Epstein-Barr virus.
@en
P2093
P2860
P1433
P1476
Prolonged inhibitory effect of ...... ication of Epstein-Barr virus.
@en
P2093
P2860
P407
P577
1984-04-01T00:00:00Z